News

As part of Building Design's Designing Tomorrow's Housing campaign, Ben Flatman visited HTA Design to hear how one of the ...
New statistical frameworks such as net treatment benefit offer a multidimensional approach to evaluating efficacy, safety, ...
Complete Response Letters recently issued by the FDA signal heightened scrutiny of trial design and reinforce the agency’s shifting regulatory expectations for sponsors and CROs.